DK0390654T3 - Aminobenzensulfonsyrederivater - Google Patents
AminobenzensulfonsyrederivaterInfo
- Publication number
- DK0390654T3 DK0390654T3 DK90400795.2T DK90400795T DK0390654T3 DK 0390654 T3 DK0390654 T3 DK 0390654T3 DK 90400795 T DK90400795 T DK 90400795T DK 0390654 T3 DK0390654 T3 DK 0390654T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- aminobenzenesulfonic acid
- acid derivatives
- alkyl group
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7468489 | 1989-03-27 | ||
JP2064811A JPH0686438B2 (ja) | 1989-03-27 | 1990-03-15 | アミノベンゼンスルホン酸誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0390654T3 true DK0390654T3 (da) | 1995-04-03 |
Family
ID=26405909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90400795.2T DK0390654T3 (da) | 1989-03-27 | 1990-03-22 | Aminobenzensulfonsyrederivater |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0390654B1 (fr) |
JP (1) | JPH0686438B2 (fr) |
AT (1) | ATE113940T1 (fr) |
CA (1) | CA2013037C (fr) |
DE (1) | DE69013959T2 (fr) |
DK (1) | DK0390654T3 (fr) |
ES (1) | ES2063300T3 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2192731C (fr) * | 1995-12-15 | 2005-09-27 | Chika Yamazaki | Monohydrates de derives d'acide aminobenzenesulfonique; methode de preparation |
AU2446297A (en) * | 1996-04-30 | 1997-11-19 | Warner-Lambert Company | Substituted piperazines and piperidines as central nervous system agents |
US5859246A (en) * | 1997-01-30 | 1999-01-12 | Neurogen Corporation | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands |
CN1109677C (zh) * | 1997-06-13 | 2003-05-28 | 三菱化学株式会社 | 氨基苯磺酸衍生物的单水合物及其制备方法 |
EP1062948B1 (fr) * | 1998-02-12 | 2010-01-06 | Mitsubishi Chemical Corporation | Medicaments contre la dysfonction diastolique non-cardiogenique |
US6407113B1 (en) | 1998-02-12 | 2002-06-18 | Mitsubishi Chemical Corporation | Medicament for treatment of diastolic dysfunction |
US7652017B2 (en) | 1999-12-21 | 2010-01-26 | Mitsubishi Tanabe Pharma Corporation | Remedies and/or preventives for nervous system disorders |
WO2002004433A2 (fr) | 2000-07-06 | 2002-01-17 | Neurogen Corporation | Ligands de recepteur d'hormone a concentration de melanine |
US20050124632A1 (en) * | 2001-03-13 | 2005-06-09 | Yoshimi Kitada | Remedies and/or preventives for diabetic ischemic heart diseases |
WO2002094799A2 (fr) | 2001-05-22 | 2002-11-28 | Neurogen Corporation | Ligands recepteurs de l'hormone de concentration de la melanine: analogues de 1-benzyl-4-aryl piperazine substituee |
CA2454681A1 (fr) * | 2001-07-25 | 2003-02-06 | Mitsubishi Pharma Corporation | Medicament inhibant un systeme d'echange sodium/calcium |
EP1419775A1 (fr) * | 2001-07-30 | 2004-05-19 | Mitsubishi Pharma Corporation | Preparations pharmaceutiques stables contenant comme principe actif des derives de l'acide aminobenzenesulphonique |
WO2004019946A1 (fr) * | 2002-08-30 | 2004-03-11 | Mitsubishi Pharma Corporation | Inhibiteurs de l'accumulation excessive d'ions sodium dans les cellules |
WO2004022545A1 (fr) * | 2002-09-06 | 2004-03-18 | Mitsubishi Pharma Corporation | Agents de protection pour organe transplante |
WO2004069275A1 (fr) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | Medicaments ophtalmiques |
KR20070026443A (ko) * | 2004-03-05 | 2007-03-08 | 미쯔비시 웰 파마 가부시키가이샤 | 허혈성 순환기 질환의 예방 및/또는 치료를 위한 약제 |
US7253168B2 (en) | 2004-04-07 | 2007-08-07 | Neurogen Corporation | Substituted 1-benzyl-4-substituted piperazine analogues |
JPWO2008010567A1 (ja) * | 2006-07-21 | 2009-12-17 | 田辺三菱製薬株式会社 | 5−メチル‐2‐(ピペラジン−1−イル)ベンゼンスルホン酸の塩形態又は溶媒和物 |
US20090318461A1 (en) | 2006-07-21 | 2009-12-24 | Chika Ohno | Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid |
WO2008032814A1 (fr) * | 2006-09-14 | 2008-03-20 | Mitsubishi Tanabe Pharma Corporation | Agent pharmaceutique contenant de l'aspirine |
US9244277B2 (en) | 2010-04-30 | 2016-01-26 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Wide angle and high resolution tiled head-mounted display device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1104514B (de) * | 1955-06-29 | 1961-04-13 | Parke Davis & Co | Verfahren zur Herstellung von blutdrucksenkend wirkenden 1-Mercaptophenyl-4-piperazino-alkoholen |
DE2040279A1 (de) * | 1970-08-13 | 1972-02-17 | Hoechst Ag | Verfahren zur Herstellung basisch substituierter Benzolsulfonamide |
DE2111811A1 (de) * | 1971-03-12 | 1972-09-14 | Hoechst Ag | Basisch substituierte Benzolsulfonylformamidine und Verfahren zu ihrer Herstellung |
DE3715763A1 (de) * | 1987-05-12 | 1988-11-24 | Hoechst Ag | Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel |
-
1990
- 1990-03-15 JP JP2064811A patent/JPH0686438B2/ja not_active Expired - Lifetime
- 1990-03-22 DK DK90400795.2T patent/DK0390654T3/da active
- 1990-03-22 AT AT90400795T patent/ATE113940T1/de not_active IP Right Cessation
- 1990-03-22 ES ES90400795T patent/ES2063300T3/es not_active Expired - Lifetime
- 1990-03-22 EP EP90400795A patent/EP0390654B1/fr not_active Expired - Lifetime
- 1990-03-22 DE DE69013959T patent/DE69013959T2/de not_active Expired - Lifetime
- 1990-03-26 CA CA002013037A patent/CA2013037C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE113940T1 (de) | 1994-11-15 |
ES2063300T3 (es) | 1995-01-01 |
JPH037263A (ja) | 1991-01-14 |
JPH0686438B2 (ja) | 1994-11-02 |
DE69013959D1 (de) | 1994-12-15 |
EP0390654B1 (fr) | 1994-11-09 |
DE69013959T2 (de) | 1995-03-16 |
EP0390654A1 (fr) | 1990-10-03 |
CA2013037A1 (fr) | 1990-09-27 |
CA2013037C (fr) | 1999-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0390654T3 (da) | Aminobenzensulfonsyrederivater | |
NO308739B1 (no) | Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme | |
DK0850926T3 (da) | Difluorprostaglandinderivater og deres anvendelse | |
AU657106B2 (en) | Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
FI914187A0 (fi) | Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta | |
MX9100227A (es) | Derivados de cefalosporina y procedimiento para su preparacion. | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
FI884088A0 (fi) | Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. | |
HK1003890A1 (en) | Optically active thiazolidinone derivatives | |
EP0785190A3 (fr) | ||
AU623500B2 (en) | Carboxylimino benzothiazole derivatives | |
NO883387L (no) | Fremgangsmaate for fremstilling av 2'-deoksy-5-fluoruridinderivater. | |
ES2032214T3 (es) | Un procedimiento para la preparacion de un derivado de ergolina. | |
DE68919869D1 (de) | Cephalosporinderivate. | |
FR2694557B1 (fr) | Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique. | |
BR9305092A (pt) | Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo |